Drug Stocks Favored by Funds

Description:

According to Robert Holmes, "Drug stocks such as Johnson & Johnson (JNJ) and Gilead Sciences (GILD) have been beaten up in the year since the health-care reform bill was passed. That may soon change, as fund managers are pouncing on shares of undervalued companies." Here are the health-care equity picks of two fund managers and an analyst. Read more here.

>>Also: 10 Buy-Rated Stocks Under $5

>>Also: 4 Small Stocks With Buyout Rumors

Most Viewed Portfolios

View All

Articles

5 Stocks Insiders Love Right Now

07.30.14 | 11:35 AM

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. They might need the cash for a big pe...

Dividend Preview: 5 Stocks Ready to Pay You More

07.30.14 | 10:47 AM

BALTIMORE (Stockpickr) -- The S&P 500 may be pushing up against new all-time highs this month, but whatever you do, don't forget about dividends. ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter